{
  "id": 12957121,
  "title": "Four Deaths Prompt FDA Safety Concerns About Novel Schizophrenia Drug",
  "url": "https://urgent.news/2026/10/08/four-deaths-prompt-fda-safety-concerns-about-novel-schizophrenia-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T20:26:21.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/psychiatry/schizophrenia/123330"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA flagged a potential safety signal after four deaths were reported among patients with treatment-resistant schizophrenia who received investigational evenamide in clinical trials, Newron Pharmaceuticals said Thursday...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}